European regulators have granted Medtronic approval for the delivery of its CoreValve transcatheter aortic valve implant using a direct aortic approach. The new delivery approach offers an alternative for patients who are not fit to receive the device through femoral artery implantation, said Kathleen Janasz at Medtronic.
Medtronic earns CE Mark for direct aortic implantation of CoreValve
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan